697  -12.18 (-1.72%)		10-30 16:00
Open: 709.425 High: 711.79 Volume: 2,089,151		Pre. Close: 709.18 Low: 691.74 Market Cap: 257,714(M)

Short term
Mid term
Targets	6-month :	831.44	1-year :	971.12
Resists	First :	711.85	Second :	831.44
Pivot price	685.62
Supports	First :	664.55	Second :	635.32
MAs	MA(5) :	697.64	MA(20) :	679.48
	MA(100) :	596.39	MA(250) :	556.78
MACD	MACD :	13.2	Signal :	12.5
%K %D	K(14,3) :	87.3	D(3) :	86
RSI	RSI(14): 59.1
52-week	High :	711.85	Low :	434.5

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ TMO ] has closed below upper band by 29.1%. Bollinger Bands are 14.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	712.36 - 715.96	715.96 - 718.27
Low:	683.18 - 687.94	687.94 - 690.98
Close:	690.17 - 697.36	697.36 - 701.95

Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Fri, 30 Oct 2026
Thermo Fisher Scientific executive vice president Michael D. Shafer to retire By Investing.com - Investing.com South Africa

Fri, 30 Oct 2026
After selling 2,831 shares, Thermo Fisher (TMO) HR chief Britt holds 11,560 directly. - Stock Titan

Fri, 30 Oct 2026
Thermo Fisher Scientific EVP Michael D. Shafer to Retire - TradingView

Fri, 30 Oct 2026
Thermo Fisher Scientific 3Q 2026: Revenue $12.14B, EPS $4.64— 10-Q Summary - TradingView

Fri, 30 Oct 2026
Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance

Thu, 29 Oct 2026
Thermo Fisher Scientific Inc. (TMO) Seasonal returns chart - Yahoo Finance UK

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	370 (M)
Shares Float	369 (M)
Held by Insiders	0.1 (%)
Held by Institutions	94 (%)
Shares Short	5,410 (K)
Shares Short P.Month	5,690 (K)

EPS	18.95
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	148.02
Profit Margin	14.9 %
Operating Margin	20.1 %
Return on Assets (ttm)	5.2 %
Return on Equity (ttm)	13.3 %
Qtrly Rev. Growth	9.1 %
Gross Profit (p.s.)	52.73
Sales Per Share	128.05
EBITDA (p.s.)	32.99
Qtrly Earnings Growth	8.6 %
Operating Cash Flow	9,320 (M)
Levered Free Cash Flow	6,450 (M)

PE Ratio	36.76
PEG Ratio	2
Price to Book value	4.7
Price to Sales	5.44
Price to Cash Flow	27.65

Dividend	0.46
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.